JO
ENSC icon

John Overdeck’s Ensysce Biosciences ENSC Stock Holding History

John Overdeck’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-222
Closed -$29.9K – 3017
2022
Q4 		$29.9K Buy
+222
New +$105K ﹤0.01% 2647

Other funds holding ENSC

VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
PIA
Powell Investment Advisors Miami, Florida $317M AUM 26.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
PMFA
Plante Moran Financial Advisors Southfield, Michigan $2.15B AUM 22.82% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

John Overdeck's ENSC Position: Q1 2023 in Review

John Overdeck sold out of Ensysce Biosciences (ENSC) in Q1 2023, closing a stake of 222 shares — an estimated $29.9K sold.

John Overdeck first reported a position in ENSC in Q4 2022 and held it in 1 quarter. The position peaked at $29.9K in Q4 2022. 8 funds tracked by Wall St. Rank hold ENSC as of Q1 2023.

  • John Overdeck reported no remaining Ensysce Biosciences position as of Q1 2023 after selling out during the quarter.
  • John Overdeck sold 222 Ensysce Biosciences shares in Q1 2023, an estimated $29.9K.
  • John Overdeck first reported a position in Ensysce Biosciences in Q4 2022 and held it in 1 quarter.
  • John Overdeck's Ensysce Biosciences position peaked at $29.9K in Q4 2022.
  • 8 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q1 2023.

Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.